Mimetis

The Bone Graft
Designed by clinicians
For clinicians

Mimetis Biomaterials is a biomedical sector company founded as a spin-off, derived from the Biomaterials, Biomechanics and Tissue Engineering (BBT) group of the Polytechnic University of Catalonia (UPC). 

The problem was that then available bone graft substitutes were outdated and unadapted to cover the increasing need for bone regeneration; the challenge was the absence of biomimetic product that allows:

  • The formation of new bone that bleeds, 
  • Good interaction with soft tissue, minimizing inflammation,
  • The possibility to customize it where patient-specific customization is needed.  

Key Opinion Leaders in the dental and orthopaedic sectors then designed and validated MimetikOss, along with researchers in Tissue Engineering; eventually everybody who participated in this process became either partner or investor.

MimetikOss answers all those features a surgeon needs in a bone graft substitute. 

Watch our president explain about Mimetis Biomaterials.

Printing biomimetic personalised bone grafts.

What are bone grafts and when are they used?

Nanostructure of MimetikOss: the only biomimetic bone graft.

Financing & Awards

Mimetis Biomaterials has been awarded as the second finalist of the Bio Emprenedor XXI award that recognizes business projects in the life sciences sector with the greatest growth potential.

Mimetis has won the IX Entrepreneur XXI Award in Catalonia, an initiative promoted by Caixa, with the support of Barcelona Activa, and co-managed by the Ministry of Industry.

The Fair rewarded the best innovations this year. MimetikOss, the first biomimetic bone graft on the market and the Mimetis team received:

  • Eureka Jury Prize
  • Eureka Innovation Award
  • Medicine and Health Award
  • Haller PRO INVENTIO Foundation Award

Mimetis has received the award for the best spin-off company of the Polytechnic University of Catalonia (UPC) 2015 by the Social Council of the UPC in the 10th edition of the Research Valorisation Award. The award distinguishes the work of the UPC research groups.

In 2017, the European Association of Economy and Competitiveness (AEDEEC) awarded the gold medal for merit at work to Mimetis Biomaterials. The medal aims to recognize the entrepreneurial spirit within the European framework to a limited selection of companies, institutions, and professional experts that belong to various sectors, and that have promoted entrepreneurial awareness and the good work of companies.

Mimetis Biomaterials has received support from the Ministry of Economy and Competitiveness through competitive public assistance NEOTEC. The support of more than € 170,000 for two years, granted by MINECO, has accelerated the development of the spin-off company of the Polytechnic University of Catalonia.

The Mimetis Biomaterials team has obtained a grant from the “Horizon Pyme 2016” line of aid for a total amount of € 63,000. The objective of this public assistance is to favor the identification and technical and economic assessment of new vital opportunities for the company, the result being a business plan for the company. The funding received has been mainly destined to the development of exhaustive market analysis at several levels, focused on the bone regeneration sector in orthopedics and traumatology.

In 2018, the Center for Industrial Technological Development (CDTI) granted a public aid of the PID line (Research and Development Projects) of 488,000 euros to Mimetis Biomaterials. The financing received is part of the funds that the company allocates to finance the research and development of the biomimetic base for bone regeneration.

Maxibone consists of different clinical and preclinical trials that aim to validate the efficacy of different biomaterials applied to the bone. Mimetis Biomaterials participates in the project of preclinical validation of biomaterials made to measure using a three-dimensional bioprinting technique: 3D microextrusion. Mimetis has received a grant of 320,000 euros for the realization of this study that will be developed over 4 years ending in 2021.

The aid for industrial doctorate aims to train doctors in companies by co-financing the employment contracts of research personnel in training who participate in an industrial research project that is developed in the company.

Our
History

  • Mimetis obtains Phase II in the Patient- Specific Biomimetic Materials for Bone Regeneration project (Bone3Dmatch). With an investment of 1.1M€, Bone3Dmatch will accelerate the market introduction of the 4th generation biomaterial in a completely new form (3D-printed scaffolds)
  • Maria Pau Ginebra, president and co-founder of Mimetis is nominated for the Women Innovator Award 2018

  • Mimetis obtains a grant of 320K€ to participate in the European project MAXIBONE

  • Mimetis obtains PID support from the Ministry of Economy and Competitiveness and starts the European project Maxibone for preclinical validation of custom made biomaterials
  • Mimetis starts a post-market clinical study on MimetikOss granules

  • CE marking of MimetikOss, synthetic bone graft
  • Mimetis closes a second round of investment of € 701k
  • Option agreement with a key player in the dental sector

  • Obtaining comparative preclinical tests superior to market standard
  • NEOTEC Public grant from the Spanish Ministry of Economy and Competitiveness
  • Entrepreneur XXI and bioentrepreneur XXI awards

  • Mimetis closes its first investment round of € 280k
  • Creation of the company
  • Patents of the biomimetic technology base

Our Partners